Annual Targeted Protein Degradation Summit 2026
A TPD and induced proximity summit focused on research from discovery through clinical development.
The Omni Boston Hotel at the Seaport, Boston, MA
- Date
- October 26, 2026
- Venue
- The Omni Boston Hotel at the Seaport, Boston, MA
TL;DR
- The 2026 summit starts October 26 in Boston, Massachusetts.
- The venue is The Omni Boston Hotel at the Seaport.
- Its stated scope spans targeted protein degradation research from early discovery to clinical development.
About
The summit returns as a forum for targeted protein degradation and induced proximity, with clinical validation among its stated themes. Its program is described as covering work from early discovery through clinical development, including target selection, degrader design, funding and partnerships.
Who you'll find in the room
Biotechs
Biotech organizations are listed among the attendee groups.
Pharma
Pharmaceutical companies are listed among the attendee groups.
Solution providers
Solution providers are listed among the attendee groups.
Academia
Academic participants are listed among the attendee groups.
Start-ups
Start-ups are listed among the attendee groups.
Featured speakers
23 listedRandy Teel
Katherine Yen
Stacy Blain
Yaron Sfadyah
Adrian Gottschalk
Anita Bellail
Catherine Sabatos-Peyton
Brian Safina
Phil Chamberlain
Arthur Sands
Beth Hoffman
Benedict Cross
Ray Deshaies
Nicki Thompson
Wolf Ruprecht Wiedemeyer
Ryan Potts
Debora Bonenfant
Stuart Schreiber
Nan Ji
Hyunsun Jo
Lan Huang
Adam Yaari
Kara Carter
Venue & travel
Venue
The Omni Boston Hotel at the SeaportQuestions people ask
5 answeredThe summit starts on October 26, 2026.
The 2026 summit is at The Omni Boston Hotel at the Seaport in Boston, Massachusetts.
Listed attendee groups include biotech and pharmaceutical companies, solution providers, academia and start-ups.
It is most useful for drug discovery and development scientists and business development staff at biotechs and pharma working on degraders or induced proximity, since the program spans early discovery to clinical data and includes speakers linked to companies such as Arvinas, Amgen and C4 Therapeutics. Those outside this modality, or seeking a broad drug discovery overview, would get less from it, and the focus on funding and partnering suits dealmakers more than bench generalists.
Attendees at Boston biotech conferences usually wear business casual, such as chinos or slacks with a button-down or sweater, and dressier for investor-facing roles. Late October in Boston is cool, so a light jacket is sensible.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in